These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19372867)

  • 1. Treatment interruption in children with HIV infection.
    Green H; Gibb DM
    Curr Opin HIV AIDS; 2007 Jan; 2(1):62-8. PubMed ID: 19372867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy interruptions: impact on HIV treatment and transmission.
    Dubrocq G; Rakhmanina N
    HIV AIDS (Auckl); 2018; 10():91-101. PubMed ID: 29942160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP; Lawrence J; Reingold AL; Tulsky JP
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
    Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.
    Yazdanpanah Y; Wolf LL; Anglaret X; Gabillard D; Walensky RP; Moh R; Danel C; Sloan CE; Losina E; Freedberg KA;
    Antivir Ther; 2010; 15(3):351-61. PubMed ID: 20516555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy.
    Wamalwa D; Benki-Nugent S; Langat A; Tapia K; Ngugi E; Moraa H; Maleche-Obimbo E; Otieno V; Inwani I; Richardson BA; Chohan B; Overbaugh J; John-Stewart GC
    AIDS; 2016 Sep; 30(15):2303-13. PubMed ID: 27177316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
    Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
    Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to planned treatment interruptions in HIV infection varies across childhood.
    Paediatric European Network for Treatment of AIDS
    AIDS; 2010 Jan; 24(2):231-41. PubMed ID: 20010073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patients.
    Babiker AG; Gibb DM
    Curr Opin HIV AIDS; 2006 Nov; 1(6):488-94. PubMed ID: 19372851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.
    Danel C; Moh R; Minga A; Anzian A; Ba-Gomis O; Kanga C; Nzunetu G; Gabillard D; Rouet F; Sorho S; Chaix ML; Eholié S; Menan H; Sauvageot D; Bissagnene E; Salamon R; Anglaret X;
    Lancet; 2006 Jun; 367(9527):1981-9. PubMed ID: 16782488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.
    Papasavvas E; Kostman JR; Mounzer K; Grant RM; Gross R; Gallo C; Azzoni L; Foulkes A; Thiel B; Pistilli M; Mackiewicz A; Shull J; Montaner LJ
    PLoS Med; 2004 Dec; 1(3):e64. PubMed ID: 15630469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials of antiretroviral treatment interruption in HIV-infected individuals.
    Lau JSY; Smith MZ; Lewin SR; McMahon JH
    AIDS; 2019 Apr; 33(5):773-791. PubMed ID: 30883388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment interruption for convenience, cost cutting and toxicity sparing.
    Nüesch R; Hirschel B
    Curr Opin HIV AIDS; 2007 Jan; 2(1):31-8. PubMed ID: 19372863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.
    Lederman MM; Penn-Nicholson A; Stone SF; Sieg SF; Rodriguez B
    Curr Opin HIV AIDS; 2007 Jan; 2(1):56-61. PubMed ID: 19372866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
    Ananworanich J; Melvin D; Amador JT; Childs T; Medin G; Boscolo V; Compagnucci A; Kanjanavanit S; Montero S; Gibb DM;
    AIDS; 2016 Apr; 30(7):1075-81. PubMed ID: 26730569
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.